RedHill Biopharma Announces Definitive Agreement for $6 Million Private Placement from OrbiMed

– RedHill Biopharma Ltd. (Nasdaq: RDHL; TASE: RDHL),  today announced that it has entered into a definitive agreement with leading healthcare investor OrbiMed Israel Partners Limited Partnership,  More...

British AstraZeneca and Israeli Hadasit Launch Drug Discovery Alliance

– AstraZeneca plc (LSE; NYSE: AZN) and Hadasit, the commercial arm and technology transfer company of Israel’s Hadassah University Hospitals, announced today they will identify, evaluate,  More...

J&J, Takeda, Orbimed consortium win biotech incubator tender

– The consortium members will receive NIS 6.9 million ($ 1.9 million) in financing over three years. –  Biotech incubator/Illustration / Getty / By Gali Weinreb / BioBoost, a consortium of OrbiMed More...